Jonathan Scott

3.0k total citations
45 papers, 1.6k citations indexed

About

Jonathan Scott is a scholar working on Immunology, Oncology and Genetics. According to data from OpenAlex, Jonathan Scott has authored 45 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Immunology, 10 papers in Oncology and 9 papers in Genetics. Recurrent topics in Jonathan Scott's work include Neutrophil, Myeloperoxidase and Oxidative Mechanisms (8 papers), Lymphoma Diagnosis and Treatment (8 papers) and Immune Response and Inflammation (7 papers). Jonathan Scott is often cited by papers focused on Neutrophil, Myeloperoxidase and Oxidative Mechanisms (8 papers), Lymphoma Diagnosis and Treatment (8 papers) and Immune Response and Inflammation (7 papers). Jonathan Scott collaborates with scholars based in United Kingdom, Canada and United States. Jonathan Scott's co-authors include Howard Abrams, Esther M. John, N. Forbath, Nancy Johnston, Allan S. Detsky, Daniel J. Drucker, Zion Sasson, Joseph Brandwein, David Sutton and A. John Simpson and has published in prestigious journals such as Nature Communications, The Journal of Experimental Medicine and Journal of Clinical Oncology.

In The Last Decade

Jonathan Scott

41 papers receiving 1.5k citations

Peers

Countries citing papers authored by Jonathan Scott

Since Specialization

Citations

This map shows the geographic impact of Jonathan Scott's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jonathan Scott with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jonathan Scott more than expected).

Fields of papers citing papers by Jonathan Scott

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jonathan Scott. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jonathan Scott. The network helps show where Jonathan Scott may publish in the future.

Co-authorship network of co-authors of Jonathan Scott

This figure shows the co-authorship network connecting the top 25 collaborators of Jonathan Scott. A scholar is included among the top collaborators of Jonathan Scott based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jonathan Scott. Jonathan Scott is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Autoimmune Hemolytic Anemia in a Patient With COVID-19 Pneumonia: A Case Report on a Rare Presentation 2023 ·Cureus ·(unknown), Jonathan Scott, (unknown), Shukaib Arslan, (unknown)	0
2	Nitration of chemokine CXCL8 acts as a natural mechanism to limit acute inflammation 2023 ·Cellular and Molecular Life Sciences ·(unknown), (unknown), Krishna Mohan Sepuru, Seppe Cambier, Thomas P Hellyer, Jonathan Scott, A. John Simpson, Paul Proost, John A. Kirby, Krishna Rajarathnam, Neil Sheerin, Simi Ali	5
3	A Matrix-Assisted Laser Desorption/Ionization Time-of-Flight Assay Identifies Nilotinib as an Inhibitor of Inflammation in Acute Myeloid Leukemia 2022 ·Journal of Medicinal Chemistry ·José Luis Marín‐Rubio, Rachel E. Heap, María Emilia Dueñas, Tiaan Heunis, (unknown), (unknown), Jonathan Scott, A. John Simpson, Helen J. Blair, Olaf Heidenreich, James M. Allan, (unknown), Mathew P. Martin, Barbara Saxty, Matthias Trost	7
4	Are foundation taster weeks an underutilised resource? 2022 ·Future Healthcare Journal ·(unknown), (unknown), Jonathan Scott	0
5	Phosphoinositide 3-Kinase δ Inhibition Improves Neutrophil Bacterial Killing in Critically Ill Patients at High Risk of Infection 2021 ·The Journal of Immunology ·Jonathan Scott, Marie‐Hélène Ruchaud‐Sparagano, Kathryn Musgrave, Alistair Roy, Stephen E. Wright, John D. Perry, Andrew Conway Morris, Anthony Rostron, A. John Simpson	5
6	C5a impairs phagosomal maturation in the neutrophil through phosphoproteomic remodeling 2020 ·JCI Insight ·Alexander Wood, (unknown), Marie‐Hélène Ruchaud‐Sparagano, Jonathan Scott, (unknown), (unknown), Kamal Kishore, Clive S. D’Santos, A. John Simpson, David Menon, Charlotte Summers, Edwin R. Chilvers, Klaus Okkenhaug, Andrew Conway Morris	23
7	Effect of Time on Human Muscle Outcomes During Simulated Microgravity Exposure Without Countermeasures—Systematic Review 2019 ·Frontiers in Physiology ·Andrew Winnard, Jonathan Scott, (unknown), (unknown), Nick Caplan	40
8	Excess Mucin Impairs Subglottic Epithelial Host Defense in Mechanically Ventilated Patients 2018 ·American Journal of Respiratory and Critical Care Medicine ·Jason Powell, James P. Garnett, Michael Mather, Faye A. H. Cooles, Andrew Nelson, Bernard Verdon, Jonathan Scott, Kasim Jiwa, Marie‐Hélène Ruchaud‐Sparagano, Stephen Cummings, John D. Perry, Stephen E. Wright, J. A. Wilson, Jeffrey P. Pearson, Chris Ward, A. John Simpson	18
9	The role of interleukin-1β as a predictive biomarker and potential therapeutic target during clinical ex vivo lung perfusion 2017 ·The Journal of Heart and Lung Transplantation ·Anders Andreasson, Lee A. Borthwick, Colin S. Gillespie, Kasim Jiwa, Jonathan Scott, Paul Henderson, Jonathan Mayes, Rosalba Romano, Marius Roman, Simi Ali, James E. Fildes, Nándor Marczin, John H. Dark, Andrew J. Fisher	50
10	Impact of the Mk VI SkinSuit on skin microbiota of terrestrial volunteers and an International Space Station-bound astronaut 2017 ·npj Microgravity ·Richard A. Stabler, (unknown), Ronan Doyle, David Negus, (unknown), (unknown), David A. Green, Rafael Franco‐Cendejas, (unknown), (unknown), Jonathan Scott, Peter W. Taylor	12
11	Exchange protein directly activated by cyclic AMP (EPAC) activation reverses neutrophil dysfunction induced by β2-agonists, corticosteroids, and critical illness 2015 ·Journal of Allergy and Clinical Immunology ·Jonathan Scott, (unknown), (unknown), James Macfarlane, Thomas P Hellyer, Anthony Rostron, Andrew Conway Morris, David Thickett, Gavin D. Perkins, Daniel F. McAuley, John Widdrington, Sarah Wiscombe, Simon Baudouin, Alistair Roy, Vanessa Linnett, Stephen E. Wright, (unknown), A. John Simpson	26
12	Immunogold labelling of leukemic hairy cells with the B‐ly7 monoclonal antibody: An SEM and TEM study 1994 ·Microscopy Research and Technique ·Étienne de Harven, Hilary Christensen, Sibrand Poppema, Jonathan Scott	1
13	High-dose etoposide and melphalan, and autologous bone marrow transplantation for patients with advanced Hodgkin's disease: importance of disease status at transplant. 1993 ·Journal of Clinical Oncology ·Michael Crump, Anne Marie Smith, Joseph Brandwein, Félix Couture, (unknown), David Sutton, Jonathan Scott, (unknown), Cindy Murray, Dominic Pantalony	134
14	Dexamethasone/ifosfamide/cisplatin/etoposide (DICE) as therapy for patients with advanced refractory non-Hodgkin's lymphoma: Preliminary report of a phase II study 1991 ·Annals of Oncology ·Paul E. Goss, Frances A. Shepherd, Jonathan Scott, Ellen Warner, Michael A. Baker, David Sutton, (unknown), (unknown), Simon Sutcliffe	19
15	Mini-beam as Salvage Chemotherapy for Refractory Hodgkin's Disease and Non-Hodgkin's Lymphoma 1991 ·Leukemia & lymphoma ·A. Keith Stewart, Joseph Brandwein, Simon Sutcliffe, Jonathan Scott, Armand Keating	23
16	Adult Acute Lymphoblastic Leukaemia: The Value of Therapy Intensification 1991 ·Leukemia & lymphoma ·Keith Stewart, Armand Keating, David Sutton, Jonathan Scott, W. H. Francombe, (unknown), Michael A. Baker	7
17	Chemotherapy following surgery for stages IE and IIE non-Hodgkin's lymphoma of the gastrointestinal tract. 1988 ·Journal of Clinical Oncology ·Frances A. Shepherd, William K. Evans, (unknown), Jonathan C. Yau, P Dang, Jonathan Scott, (unknown), W. H. Francombe, Denis Bailey, M. A. Baker	62
18	Efficacy of 2'-Deoxycoformycin in Hairy-Cell Leukemia: A Study of the National Cancer Institute of Canada Clinical Trials Group1 1988 ·JNCI Journal of the National Cancer Institute ·James B. Johnston, Elizabeth A. Eisenhauer, W. E. N. Corbett, Jonathan Scott, S. Donald Zaentz	72
19	Further Studies on the Mechanism of Antibody-Complement Induced Hemolysis: Specificity of Complement 1966 ·The Journal of Immunology ·Jonathan Scott, Robert I. Weed, Scott N. Swisher	10
20	HEMOGLOBIN C DISEASE IN A SICILIAN-CANADIAN FAMILY. 1963 ·PubMed ·Jonathan Scott, (unknown), J. H. Crookston	3

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact